Ameya Asarkar, MD
Otolaryngology · Shreveport, LANPI 1215484647
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,509 of the $8,377 with a category attached, or 89.6%. 24 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 37.2% of the total. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $37.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Johnson & Johnson$1K
- Intuitive Surgical$1K
- Medtronic$889
- Intersect ENT, Inc.$206
- Sanofi$198
- plus $2K from 18 others
What the payments were for
- Travel & lodging$84810%
- Food & beverage$7,50990%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 129 | $3,115 |
| Johnson & Johnson | 13 | $1,284 |
| Intuitive Surgical | 6 | $1,054 |
| Medtronic(2 entities) | 12 | $889 |
| Intersect ENT, Inc. | 3 | $206 |
| Sanofi | 11 | $198 |
| Olympus America Inc. | 2 | $194 |
| Regeneron Healthcare Solutions, Inc. | 3 | $163 |
| Boehringer Ingelheim | 5 | $144 |
| Genentech USA, Inc. | 8 | $144 |
| Axogen | 4 | $135 |
| Davol Inc. | 1 | $125 |
| Integra Lifesciences Corporation | 1 | $123 |
| Tempus AI, Inc | 5 | $119 |
| Tactile Systems Technology Inc | 2 | $100 |
| Inogen, Inc. | 5 | $74 |
| AstraZeneca | 4 | $70 |
| Livanova USA, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Grifols USA, LLC | 2 | $36 |
| Electromed, Inc. | 2 | $29 |
| Aerin Medical Inc. | 1 | $28 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| Covidien LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRUMATCH$922
- Inspire$852
- Da Vinci Surgical System$792
- Inspire Upper Airway Stimulation System$474
- NIM Vital$320
- STEALTHSTATION S8 PLATFORM$257
- MATRIXMIDFACE$228
- RHINO-LARYNGO VIDEOSCOPE$145
- SINUVA$134
- Phasix Mesh$125
- AMNIOEXCEL$123
- PRIMATRIX$123
- MEDIHONEY$123
- TCC-EZ$123
- OMNIGRAFT$123
- MATRIXMANDIBLE$123
How this compares
$8,377 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Shreveport
- Michael YimShreveport$77K
- Maura CosettiShreveport$64K
- Cherie-Ann NathanShreveport$32K
- Vikas MehtaShreveport$8K
- Roger BuiShreveport$5K
- Jason CalligasShreveport$5K
- Adam BlancherShreveport$4K
- Rodrigo Martinez MonederoShreveport$3K
- Karuna DewanShreveport$3K
- Donald GonzalesNew Orleans$351K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.